Amneal Pharmaceuticals, Inc. AMRX United States — Long-Lived Assets

Other geography segments

Similar metrics at other companies

PANWUnited States — Long-Lived Assets

$418M-4.8%

WWWUnited States — Long-Lived Assets

$105.5M-10.3%

NCNOUnited States — Long-Lived Assets

$69.19M-10.7%

FRHCUnited states — Long-Lived Assets

$9.42M+42.6%

TTC

TTCUnited States — Long-Lived Assets

$572.6M-1.7%

AESUNITED STATES — Long-Lived Assets

$29.23B+15.7%

FAQ

What is Amneal Pharmaceuticals, Inc.'s united states — long-lived assets?

Amneal Pharmaceuticals, Inc. (AMRX) reported united states — long-lived assets of $313.51M in Q4 2025.

How has Amneal Pharmaceuticals, Inc.'s united states — long-lived assets changed year-over-year?

Amneal Pharmaceuticals, Inc.'s united states — long-lived assets increased by 0.9% year-over-year, from $310.7M to $313.51M.

What does united states — long-lived assets mean?

This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally domiciled within the United States. It reflects the company's capital investment in regional manufacturing facilities, distribution infrastructure, and localized intellectual property portfolios. Monitoring this balance helps investors assess the geographic concentration of production capacity and the scale of operational footprint within the domestic market.